Fixed drug eruption secondary to ondansetron.
Iglesias
M E
ME
España
A
A
Redondo
P
P
Quintanilla
E
E
D000932:Antiemetics / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced; D007167:Immunotherapy; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D017294:Ondansetron / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy
D000932:Antiemetics; D017294:Ondansetron